FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220687070> ?p ?o ?g. }

• W4220687070 endingPage "1145" @default.
• W4220687070 startingPage "1133" @default.
• W4220687070 abstract "Background Clinical considerations for drug treatment of acute seizures involve variables such as safety, tolerability, drug-drug interactions, dosage, route of administration, and alterations in pharmacokinetics because of critical illness. Therapy options that are easily and quickly administered without dilution, well tolerated, and effective are needed for the treatment of acute seizures. The objective of this review is to focus on the clinical considerations relating to the use of intravenous brivaracetam (IV BRV) for the treatment of acute seizures in the hospital, focusing on critically ill patients. Methods This was a scoping literature review of PubMed from inception to April 13, 2021, and search of the American Academy of Neurology (AAN) 2021 Annual Meeting website for English language publications/conference abstracts reporting the results of IV BRV use in hospitalized patients, particularly in the critical care setting. Outcomes of interest relating to the clinical pharmacology, safety, tolerability, efficacy, and effectiveness of IV BRV were reviewed and are discussed. Results Twelve studies were included for analysis. One study showed that plasma concentrations of IV BRV 15 min after the first dose were similar between patients receiving IV BRV as bolus or infusion. IV BRV was generally well tolerated in patients with acute seizures in the hospital setting, with a low incidence of individual TEAEs classified as behavioral disorders. IV BRV demonstrated efficacy and effectiveness and had a rapid onset, with clinical and electrophysiological improvement in seizures observed within minutes. Although outside of the approved label, findings from several studies suggest that IV BRV reduces seizures and is generally well tolerated in patients with status epilepticus. Conclusions IV BRV shows effectiveness, and is generally well tolerated in the management of acute seizures in hospitalized patients where rapid administration is needed, representing a clinically relevant antiseizure medication for potential use in the critical care setting." @default.
• W4220687070 created "2022-04-03" @default.
• W4220687070 creator A5011757795 @default.
• W4220687070 creator A5030664816 @default.
• W4220687070 creator A5030901765 @default.
• W4220687070 creator A5036204847 @default.
• W4220687070 creator A5089554375 @default.
• W4220687070 date "2022-03-21" @default.
• W4220687070 modified "2023-09-27" @default.
• W4220687070 title "Intravenous Brivaracetam in the Management of Acute Seizures in the Hospital Setting: A Scoping Review" @default.
• W4220687070 cites W1543660680 @default.
• W4220687070 cites W1916788136 @default.
• W4220687070 cites W1943229448 @default.
• W4220687070 cites W1967996835 @default.
• W4220687070 cites W1976648341 @default.
• W4220687070 cites W1992028227 @default.
• W4220687070 cites W2001726077 @default.
• W4220687070 cites W2006722190 @default.
• W4220687070 cites W2029569324 @default.
• W4220687070 cites W2037426360 @default.
• W4220687070 cites W2040009475 @default.
• W4220687070 cites W2041090550 @default.
• W4220687070 cites W2051013481 @default.
• W4220687070 cites W2065885918 @default.
• W4220687070 cites W2075950485 @default.
• W4220687070 cites W2079228982 @default.
• W4220687070 cites W2082136405 @default.
• W4220687070 cites W2091074713 @default.
• W4220687070 cites W2095271866 @default.
• W4220687070 cites W2095415351 @default.
• W4220687070 cites W2099690974 @default.
• W4220687070 cites W2116451916 @default.
• W4220687070 cites W2127801604 @default.
• W4220687070 cites W2152668905 @default.
• W4220687070 cites W2195450118 @default.
• W4220687070 cites W2394919271 @default.
• W4220687070 cites W2419659369 @default.
• W4220687070 cites W2471268248 @default.
• W4220687070 cites W2513307797 @default.
• W4220687070 cites W2557505699 @default.
• W4220687070 cites W2586478317 @default.
• W4220687070 cites W2607319988 @default.
• W4220687070 cites W2773535406 @default.
• W4220687070 cites W2783522776 @default.
• W4220687070 cites W2786832455 @default.
• W4220687070 cites W2801009351 @default.
• W4220687070 cites W2807729904 @default.
• W4220687070 cites W2810793837 @default.
• W4220687070 cites W2883005533 @default.
• W4220687070 cites W2883620991 @default.
• W4220687070 cites W2885322963 @default.
• W4220687070 cites W2894903954 @default.
• W4220687070 cites W2895168066 @default.
• W4220687070 cites W2902610243 @default.
• W4220687070 cites W2903035030 @default.
• W4220687070 cites W2903568738 @default.
• W4220687070 cites W2920876248 @default.
• W4220687070 cites W2930649354 @default.
• W4220687070 cites W2956081863 @default.
• W4220687070 cites W2957115440 @default.
• W4220687070 cites W2966616847 @default.
• W4220687070 cites W2971903738 @default.
• W4220687070 cites W2973225802 @default.
• W4220687070 cites W2990087681 @default.
• W4220687070 cites W2999631457 @default.
• W4220687070 cites W3015500662 @default.
• W4220687070 cites W3024851430 @default.
• W4220687070 cites W3025665915 @default.
• W4220687070 cites W3048522953 @default.
• W4220687070 cites W3087515083 @default.
• W4220687070 cites W3106714849 @default.
• W4220687070 cites W3107177056 @default.
• W4220687070 cites W3107933832 @default.
• W4220687070 cites W3121047679 @default.
• W4220687070 cites W3129076955 @default.
• W4220687070 cites W4211229072 @default.
• W4220687070 cites W4213431706 @default.
• W4220687070 cites W4252248565 @default.
• W4220687070 doi "https://doi.org/10.1177/08850666211073598" @default.
• W4220687070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35306914" @default.
• W4220687070 hasPublicationYear "2022" @default.
• W4220687070 type Work @default.
• W4220687070 citedByCount "3" @default.
• W4220687070 countsByYear W42206870702023 @default.
• W4220687070 crossrefType "journal-article" @default.
• W4220687070 hasAuthorship W4220687070A5011757795 @default.
• W4220687070 hasAuthorship W4220687070A5030664816 @default.
• W4220687070 hasAuthorship W4220687070A5030901765 @default.
• W4220687070 hasAuthorship W4220687070A5036204847 @default.
• W4220687070 hasAuthorship W4220687070A5089554375 @default.
• W4220687070 hasBestOaLocation W42206870701 @default.
• W4220687070 hasConcept C118552586 @default.
• W4220687070 hasConcept C126322002 @default.
• W4220687070 hasConcept C16568411 @default.
• W4220687070 hasConcept C177713679 @default.
• W4220687070 hasConcept C197934379 @default.
• W4220687070 hasConcept C2778186239 @default.
• W4220687070 hasConcept C2778375690 @default.

• next